Emerging cephalosporin and multidrug-resistant gonorrhoea in Europe.
暂无分享,去创建一个
M. Unemo | G. Spiteri | M. J. van de Laar | M. Cole | S. Chisholm | S. Hoffmann | C. Ison | M. J. W. Laar
[1] M. Unemo,et al. Antimicrobial Resistance in Neisseria gonorrhoeae in the 21st Century: Past, Evolution, and Future , 2014, Clinical Microbiology Reviews.
[2] M. Unemo,et al. The European Gonococcal Antimicrobial Surveillance Programme (Euro-GASP)—a sentinel approach in the European Union (EU)/European Economic Area (EEA) , 2013, Sexually Transmitted Infections.
[3] M. Unemo,et al. Phenotypic and genetic characterization of the first two cases of extended-spectrum-cephalosporin-resistant Neisseria gonorrhoeae infection in South Africa and association with cefixime treatment failure. , 2013, The Journal of antimicrobial chemotherapy.
[4] M. Unemo,et al. 2012 European guideline on the diagnosis and treatment of gonorrhoea in adults , 2013, International journal of STD & AIDS.
[5] I. Martin,et al. Neisseria gonorrhoeae treatment failure and susceptibility to cefixime in Toronto, Canada. , 2013, JAMA.
[6] M. Unemo,et al. Emergence of multidrug-resistant, extensively drug-resistant and untreatable gonorrhea. , 2012, Future microbiology.
[7] R. Kirkcaldy,et al. Effectiveness of gentamicin for gonorrhoea treatment: systematic review and meta-analysis , 2012, Postgraduate Medical Journal.
[8] G. Spiteri,et al. Increasing trends of gonorrhoea and syphilis and the threat of drug-resistant gonorrhoea in Europe. , 2012, Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin.
[9] M. Unemo,et al. The serious threat of multidrug-resistant and untreatable gonorrhoea: the pressing need for global action to control the spread of antimicrobial resistance, and mitigate the impact on sexual and reproductive health , 2012, Sexually Transmitted Infections.
[10] M. Unemo,et al. The European gonococcal antimicrobial surveillance programme, 2009. , 2011, Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin.
[11] M. Unemo,et al. An evaluation of gentamicin susceptibility of Neisseria gonorrhoeae isolates in Europe. , 2011, The Journal of antimicrobial chemotherapy.
[12] D. Lewis. The Gonococcus fights back: is this time a knock out? , 2010, Sexually Transmitted Infections.
[13] M. Unemo,et al. Meeting the public health challenge of multidrug- and extensively drug-resistant Neisseria gonorrhoeae , 2009, Expert review of anti-infective therapy.
[14] J. Tapsall,et al. Surveillance of antibiotic resistance in Neisseria gonorrhoeae in the World Health Organization Western Pacific Region, 2003. , 2005, Communicable diseases intelligence quarterly report.
[15] M. Yasuda,et al. Treatment of uncomplicated gonococcal urethritis by double-dosing of 200 mg cefixime at a 6-h interval , 2003, Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy.
[16] I Lind,et al. Antimicrobial resistance in Neisseria gonorrhoeae. , 1997, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[17] J. Moran. Treating Uncomplicated Neisseria gonorrhoeae Infections: Is the Anatomic Site of Infection Important? , 1995, Sexually transmitted diseases.